中国药房2017，Vol.28Issue(32)：4474-4478,5.DOI:10.6039/j.issn.1001-0408.2017.32.03
孤儿药研发的经济学分析
Economic Analysis of Orphan Drug Research and Development
摘要
Abstract
OBJECTIVE:To analyze the research and development (R&D) of orphan drug in China from the respect of economics,and to provide suggestions for the development and policy formulation of orphan drug in China.METHODS:The theories of external economy and transaction costs were adopted to analyze the reasons about no enthusiasm in orphan drug R&D,and find some appropriate solutions for them.RESULTS:Orphan drug was still lack of identification standard in China.The extemal economy,much of transaction costs in orphan drug and R&D risk aggravated the economic burden on pharmaceutical enterprises,combated R&D and production enthusiasm of pharmaceutical enterprises.CONCLUSIONS:Chinese pharmaceutical enterprises can take part in orphan drug cooperative R&D,and play the advantage of TCM treatment so as to reduce R&D cost.The government should establish and develop orphan drug system,play the role of taxation and health insurance,accelerate approval,give market exclusivity for pharmaceutical enterprises and encourage cooperative R&D.关键词
孤儿药/外部性/交易费用/研发/经济学分析Key words
Orphan drug/External/Transaction costs/Research and development/Economic analysis分类
医药卫生引用本文复制引用
俞江婷,王艳翚,华东..孤儿药研发的经济学分析[J].中国药房,2017,28(32):4474-4478,5.基金项目
四川省哲学社会科学重点研究基地、四川医事卫生法治研究中心项目(No.YF16-Y08) （No.YF16-Y08）
